Dr. Doojin Kim, MD

Dr. Kim practices at Regents of the University of California Los Angeles in Santa Monica, California.

Dr. Kim's NPI, 1487679858, was assigned on July 13, 2006. Dr. Kim graduated from UC San Diego School of Medicine in 2000. Dr. Kim holds California license A76453.

Dr. Kim's primary practice is Regents of the University of California Los Angeles, at 1801 Wilshire Blvd, Santa Monica, CA 90403 in Los Angeles County. The practice phone is (310) 391-7281.

Dr. Kim's primary practice is Regents of the University of California Los Angeles in Santa Monica, California. Dr. Kim is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is Martin Luther King Jr. Community Medical Group. Dmand AI also links Dr. Kim to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kim is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kim's licenses on file in 10 states: California, Michigan, New Jersey, Arkansas, Iowa, Kentucky, New York, Indiana, Nevada and Oklahoma.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Kim treats.

CMS data shows 1,350 Medicare services from Dr. Kim across 8 procedure codes in 2024, for 656 Medicare patients. Medicare paid $151,664 for them.

CMS counts 656 Medicare patients who saw Dr. Kim in 2024. The largest group is 75 to 84, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 62, with 57% women.

In 2024, Dr. Kim wrote 1,533 Medicare Part D claims for 274 patients. 89% of them were for generic drugs. CMS names the drug for 1,296 of them, across 40 drugs with 11 or more claims each, at $174,534 in total drug cost. In 2023, CMS named 1,290 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kim for performance year 2024, reported through an alternative payment model (APM). Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth.

Dmand AI links 91 papers to Dr. Kim, published from 2001 to 2020. 2016 was the busiest year, with 6. The most frequent topics are Korea, Magnetic Resonance Imaging and Molecular Sequence Data. Dr. Kim has published most often in Phys Rev Lett. Dr. Kim's most frequent co-authors are Paul M. Vespa, MD, James C. Grotta, MD and Brett Cowan Meyer, MD.

CMS Open Payments shows 860 general payments to Dr. Kim from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. TG Therapeutics, Inc. paid the most, $19,471.

Dr. Kim graduated from UC San Diego School of Medicine in 2000. Dr. Kim is a member of AAN.

Dr. Kim is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.